Two recent announcements from major retail healthcare players could reshape the value-based primary care landscape.
Walmart’s potential acquisition of Medicare Advantage-focused primary care group ChenMed could launch the retailer into the center of a value-based care turf war. ChenMed is a prize asset—the last independent, scaled senior primary care group other than beleaguered Cano Health.
Meanwhile, Walgreens’ strategic partnership with VC-backed value-based care enabler Pearl Health marks the first major strategic deal between a VBC enabler and a retail healthcare player—a combination we expect to see more of in the future.
PitchBook’s lead healthcare analyst Rebecca Springer unpacks the immediate and long-term implications of these moves. Read more.
